CTT PHARMACEUTICAL HOLDINGS, INC.
CIK 1035422 · CEO · last filed 2025-12-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
0
Total Filings
50
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| No companies on record. | |||||||
Recent Filings · Page 5 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-08 | — | Buy (P) | +4,388 | $136 | |
| 2024-05-08 | — | Buy (P) | +9,500 | $380 | |
| 2023-10-31 | — | Buy (P) | +500,000 | $10.0K | |
| 2023-10-31 | — | Buy (P) | +500,000 | $10.0K | |
| 2023-10-31 | — | Grant (A) | +500,000 | $10.0K | |
| 2023-03-27 | — | Buy (P) | +8,700 | $191 | |
| 2023-03-03 | — | Buy (P) | +3,840 | $134 | |
| 2023-02-08 | — | Buy (P) | +4,960 | $174 | |
| 2023-01-30 | — | Buy (P) | +9,000 | $225 | |
| 2023-01-25 | — | Buy (P) | +61,695 | $1.5K |
Showing 41–50 of 50
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.